Bone Marrow Transplantation Market
Bone Marrow Transplantation Market Study by Autologous and Allogeneic Bone Marrow Transplantation for Leukemia, Lymphoma, Myeloma, Myelodysplasia, Myeloproliferative and Others from 2024 to 2034
Analysis of Bone Marrow Transplantation Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Bone Marrow Transplantation Market Outlook (2024 to 2034)
The global bone marrow transplantation market size is set to account for a valuation of US$ 11.17 billion in 2024 and is projected to expand at 3.7% CAGR through 2034. As a result, worldwide revenue from bone marrow transplantation is projected reach US$ 16 billion by 2034-end.
As the name suggests, bone marrow transplantation is the process of replacing the existing damaged or disease-affected bone marrow with healthy stem cells. These cells are usually derived from another donor with a similar genetic profile or taken from the peripheral blood or umbilical cord blood of the patient.
Surging incidence of leukemia and other types of blood cancers around the world is the primary aspect that is forecasted to uplift the demand for bone marrow transplantation over the next 10 years. Growing prevalence of Hodgkin lymphoma, myeloma, non-Hodgkin lymphoma, and thalassemia is also estimated to contribute to the steadily increasing bone marrow transplantation market size.
- Bone marrow transplantation for the treatment of leukemia is forecasted to account for a market valuation of US$ 3.9 billion by the end of 2034.
Advancements in stem cell technology, wide availability of novel stem cell therapies, rising investments in blood cancer R&D, growing awareness regarding the benefits of bone marrow transplant, and increasing per capita healthcare expenditure are other factors that could cushion demand for bone marrow transplantation devices and services going forward.
High costs associated with bone marrow transplantation procedures and the shortage of bone marrow donors are projected to be key bone marrow transplantation market trends that impede global revenue generation in the long run. The rapidly expanding geriatric population around the world is also estimated to boost bone marrow transplantation market growth through 2034.
| Report Attributes | Details |
|---|---|
| Bone Marrow Transplantation Market Size (2024E) | US$ 11.17 Billion |
| Projected Market Value (2034F) | US$ 16 Billion |
| Global Market Growth Rate (2024 to 2034) | 3.7% CAGR |
| China Market Value (2034F) | US$ 599.2 Million |
| Canada Market Growth Rate (2024 to 2034) | 4.2% CAGR |
| North America Market Share (2024E) | 33.1% |
| Autologous Bone Marrow Transplantation Demand Growth (2024 to 2034) | 3.3% CAGR |
| East Asia Market Value (2034F) | US$ 1.48 Billion |
| Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
How Can Start-ups Revolutionize the Bone Marrow Transplantation Landscape?
“Focus on Development of Advanced Monitoring Solutions to Improve Patient Outcomes”
Bone marrow transplantation is a complex and long process, which is why patient monitoring in the pre and post-surgery stages is of the essence. New companies looking to enter the bone marrow transplant space are focusing on providing advanced monitoring solutions to improve patient outcomes from bone marrow transplantation surgeries.
- In November 2023, BioIntelliSense, a new company founded in 2018 providing health monitoring and clinical intelligence solutions along with UC Davis Health, announced the launch of a new continuous monitoring program for bone marrow transplant patients. The program incorporates the use of BioButton wearable devices to monitor subtle changes in vital signs and identify the signs of patient deterioration to promote better clinical decision-making.
Surging adoption of stem cell therapies in bone marrow transplantation and the growing popularity of regenerative medicine are opening up avenues of opportunities for new companies. Bone marrow transplant providers are focusing on raising capital to finance their research and compete with established market players.
- In September 2021, Garuda Therapeutics, a start-up focusing on eliminating the dependency on blood stem cell transplants, announced its launch with a Series A funding round of US$ 72 million. The oversubscribed financing round was led by Orbimed, Aisling Capital, and Northpond Ventures with participation from other investors.
Start-ups can gain a detailed understanding of factors such as local supply, pricing trends, product standards, safety regulations, and new developments from this bone marrow transplantation market research report by skilled analysts at Fact.MR, a market research and competitive intelligence provider.
Country-wise Insights
High prevalence of blood cancers and a growing geriatric population are estimated to be common prospects that drive bone marrow transplantation demand in countries such as India, China, the United States, Japan, Germany, Italy, and Australia over the next 10 years and beyond.
What Makes the United States a Key Market for Bone Marrow Transplant Providers?
“Increasing Geriatric Population and Presence of Well-established Healthcare Infrastructure”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 3.45 Billion |
| Growth Rate (2024 to 2034) | 4.1% CAGR |
| Projected Value (2034F) | US$ 5.17 Billion |
Developed healthcare infrastructure of the United States coupled with high healthcare spending potential offers a fertile ground for bone marrow transplantation companies to boost their business. The increasing senescent population of the United States is also projected to drive demand for bone marrow transplantation services as older people are more inclined to need bone transplants as compared to younger people.
Presence of key bone marrow transplantation providers and rapid adoption of advanced therapies and treatments is projected to enable the United States to hold a prominent chunk of the North American bone marrow transplantation market by 2034.
Why Should Bone Marrow Transplantation Providers Target India?
“High Incidence of Blood Cancers and Sickle Cell Anemia”
The tribal population of India is at a high risk of sickle cell anemia, and this is projected to augment demand for bone marrow transplantation in the country over the coming years. The Indian government is making several efforts to manage the incidence of sickle cell anemia by launching different screening and awareness programs in the country.
- In July 2023, the Prime Minister of India announced the launch of a sickle cell anemia elimination mission that was aimed at screening young tribals in the country. This mission is part of the Indian government’s plan to eradicate sickle cell anemia in the country by 2047.
Increasing availability of novel bone marrow transplantation procedures and growing healthcare expenditure are also projected to create new opportunities for bone marrow transplantation companies in India over the forecast period.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Category-wise Insights
Bone marrow transplant providers are focusing on providing allogeneic transplants in hospital settings to maximize their revenue generation across the study period and beyond.
Which Type of Bone Marrow Transplant Accounts for High Revenue Streams?
“Growing Demand for Allogeneic Bone Marrow Transplant Due to Higher Success Rate”
| Attribute | Allogeneic Bone Marrow Transplantation |
|---|---|
| Segment Value (2024E) | US$ 7.36 Billion |
| Growth Rate (2024 to 2034) | 3.8% CAGR |
| Projected Value (2034F) | US$ 10.71 Billion |
An allogeneic bone marrow transplant is a type of transplantation procedure where the donor shares the same genetic type as the patient. Usually, this type of transplant involves familial donors such as brothers and sisters. In this type of transplantation, the transplanted graft is free from any contamination or disease, which is why it has a better success rate as compared to autologous bone marrow transplantation. All of the aforementioned factors contribute to the dominant market share of allogeneic bone marrow transplantation.
Where are Most Bone Marrow Transplants Performed?
“Hospitals Account for Leading Market Share Due to Comprehensive Post-Procedure Care”
| Attribute | Hospitals |
|---|---|
| Segment Value (2024E) | US$ 10.35 Billion |
| Growth Rate (2024 to 2034) | 3.7% CAGR |
| Projected Value (2034F) | US$ 14.83 Billion |
Bone marrow transplantation is a complex procedure that requires skilled medical professionals and advanced medical devices. Both of the requisites are met in a hospital setting, and this is why most patients get their bone marrow transplantation procedures done in hospitals around the world. Better post-procedure care and improved patient outcomes are also factors that contribute to a higher number of bone marrow transplantation surgeries being performed in hospitals as compared to other healthcare establishments.
Competitive Landscape
Bone marrow transplantation service providers are projected to benefit from supportive government initiatives that are being launched to increase awareness about bone marrow transplants and other related diseases such as leukemia, lymphoma, and thalassemia.
- In October 2023, the American Oncology Institute, a renowned cancer care provider in the South Asian region, announced the launch of its bone marrow transplantation program in India. The company aims to bolster its services in India on the back of the rising incidence of different types of cancers, which is pushing the demand for bone marrow transplantation services.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Key Segments of Bone Marrow Transplantation Market Research
-
By Transplant Type:
- Autologous Bone Marrow Transplantation
- Allogeneic Bone Marrow Transplantation
-
By Indication:
- Leukemia
- Lymphoma
- Myeloma
- Myelodysplasia
- Myeloproliferative Neoplasms
- Aplastic Anemia
- Solid Tumors
- Sickle Cell Anemia
- Thalassemia
- Others
-
By End User:
- Hospitals
- Multispecialty Clinics
- Ambulatory Surgical Centers
-
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- Middle East & Africa
- FAQs -
How big is the bone marrow transplantation market?
The global bone marrow transplantation market is estimated at US$ 11.17 billion in 2024.
What is the demand projection for bone marrow transplantation solutions for 2034?
Demand for bone marrow transplantation is forecasted to reach a market value of US$ 16 billion by 2034-end.
At what rate are the sales of bone marrow transplantation services forecasted to rise?
Sales of bone marrow transplantation services are set to rise at a slow 3.7% CAGR through 2034.
Which region accounts for high demand for bone marrow transplantation?
The market in North America is predicted to increase at a CAGR of 4.1% from 2024 to 2034.
Which type of bone marrow transplantation is highly popular?
Allogeneic bone marrow transplantation is widely adopted for the treatment several indications.
Who are the top bone marrow transplantation providers?
Merck Millipore Corporation, ATCC Inc., Sanofi-Aventis LLC, PromoCell GmbH, ReeLabs Pvt. Ltd., Mesoblast Ltd., and HemaCare are key companies in the market.
Bone Marrow Transplantation Market
*Mail attachment includes 112 figures & 84 tables